Received May 28, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Z008872 | OT |
No additional AE; TE evaluation for VARIVAX and stated that the product was administered.; This spontaneous report was received from a pharmacy technician and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, previous drug reactions, drug allergies and concomitant therapies were not reported. On 03-May-2026, the patient was vaccinated with an improperly stored first dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) 0.5 mL, given intramuscularly, involved lot # Z008872 has been verified to be valid with expiration date: 14-May-2027, and which was reconstituted in a sterile diluent syringe (BAXTER STERILE DILUENT), lot # Z009739 has been verified to be valid with expiration date: 25-Apr-2028; given as prophylaxis (Site administration not reported). The administered dose of the vaccine experienced a temperature excursion from 72F (47°F to 77°F) for 1 hours 0 minutes. No previous temperature excursion was reported. There was no adverse effect reported. No product quality complaint was involved.
DILUENT MRK INJ